We are live on ! Find out more
FC

Fore Capital Portfolio holdings

AUM $338M
1-Year Est. Return 10.07%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+10.07%
3 Year Est. Return
+25.37%
5 Year Est. Return
+23.47%
10 Year Est. Return
AUM
$294M
AUM Growth
+$99.4M
Cap. Flow
-$48.6M
Cap. Flow %
-16.51%
Top 10 Hldgs %
77.87%
Holding
65
New
15
Increased
5
Reduced
5
Closed
20

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.06M
2
SHC icon
Sotera Health
SHC
+$1.32M
3
SLV icon
iShares Silver Trust
SLV
+$1.08M
4
SNY icon
Sanofi
SNY
+$989K
5
SILC icon
Silicom
SILC
+$931K

Sector Composition

Rank Sector Weight
1 Miscellaneous 96.33%
2 Healthcare 1.64%
3 Technology 0.81%
4 Materials 0.39%
5 Utilities 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
26
Viatris
VTRS
$18.8B
$135K 0.05%
+10,000
New +$134K
MTNB icon
27
Matinas BioPharma
MTNB
$2.94M
$10K ﹤0.01%
200
ASHR icon
28
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.56B
-10,000
Closed -$381K
OPTU
29
CALL
Optimum Communications Inc
OPTU
$389M
-135,000
Closed -$2.8M
OPTU
30
Optimum Communications Inc
OPTU
$389M
-30,000
Closed -$622K
OPTU
31
PUT
Optimum Communications Inc
OPTU
$389M
-100,000
Closed -$2.07M
EPD icon
32
PUT
Enterprise Products Partners
EPD
$84.3B
-50,000
Closed -$1.08M
EQT icon
33
EQT Corp
EQT
$34.1B
-50,000
Closed -$1.02M
GDX icon
34
CALL
VanEck Gold Miners ETF
GDX
$31B
-150,000
Closed -$4.42M
ILCV icon
35
PUT
iShares Morningstar Value ETF
ILCV
$1.36B
-200,000
Closed -$17.5M
INO icon
36
CALL
Inovio Pharmaceuticals
INO
$133M
-8,333
Closed -$716K
IQ icon
37
CALL
iQIYI
IQ
$888M
-100,000
Closed -$803K
MRK icon
38
CALL
Merck
MRK
$366B
-150,000
Closed -$11.3M
OGN icon
39
Organon & Co
OGN
$3.61B
-45,000
Closed -$1.48M
STNG icon
40
PUT
Scorpio Tankers
STNG
$3.91B
-112,000
Closed -$2.08M
T icon
41
CALL
AT&T
T
$178B
-198,600
Closed -$4.05M
T icon
42
AT&T
T
$178B
-92,680
Closed -$1.89M
T icon
43
PUT
AT&T
T
$178B
-92,680
Closed -$1.89M
VST icon
44
PUT
Vistra
VST
$46B
-50,000
Closed -$855K
VZ icon
45
CALL
Verizon
VZ
$208B
-130,000
Closed -$7.02M
AUD
46
DELISTED
Audacy, Inc.
AUD
-150,000
Closed -$552K
XDIV
47
DELISTED
U.S. Equity Ex-Dividends Fund - Series 2027
XDIV
-149,997
Closed -$14.5M

Similar funds

Fore Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Fore Capital held 65 positions worth $294M, up 51% from $195M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Fore Capital withdrew a net $48.6M in Q4 2021, closing 20 positions and reducing 5 holdings. Its most notable exit was U.S. Equity Ex-Dividends Fund - Series 2027, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 95% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Fore Capital opened a new position in AstraZeneca worth $2.04M.

  • Fore Capital's largest Q4 2021 buy was AstraZeneca: 17,500 shares worth $2.04M.
  • Fore Capital added most to Silicom in Q4 2021, an estimated $931K increase.
  • Fore Capital's biggest Q4 2021 reduction was Enterprise Products Partners, cutting an estimated $673K.
  • Fore Capital fully exited U.S. Equity Ex-Dividends Fund - Series 2027 in Q4 2021, selling an estimated $14.5M.
  • Fore Capital's ten largest holdings make up 78% of its $294M portfolio in Q4 2021.
  • Fore Capital opened 15 new positions and closed 20 in Q4 2021.
  • Fore Capital's portfolio value rose 51% quarter-over-quarter to $294M.

Based on Fore Capital's 13F filing for Q4 2021, filed 11 Feb 2022.